Species differences in angiotensin II generation and degradation by mast cell chymases

Journal of Receptors and Signal Transduction

Volumn 25, Issue 1, 2005, Pages 35-44

  Kunori, Yuichi ^a   Muroga, Yumiko ^a   Iidaka, Minako ^a   Mitsuhashi, Hiroaki ^a   Kamimura, Takashi ^a   Fukamizu, Akiyoshi ^b  

^a TEIJIN LTD   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Angiotensin I; Angiotensin II; Chymase; Kinetic study; Species differences

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN[5-10][5 ISOLEUCINE 6 HISTIDINE 7 PROLINE 8 PHENYLALANINE 9 HISTIDINE 10 LEUCINE]; CHYMASE; HISTIDINE; ISOLEUCINE; MAST CELL PROTEASE 4; PEPTIDE; PHENYLALANINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DOG; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME KINETICS; HAMSTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; IONIC STRENGTH; NONHUMAN; PH; SPECIES DIFFERENCE;

ANGIOTENSIN II; ANIMALS; CHYMASES; CRICETINAE; DOGS; HUMANS; KINETICS; MAST CELLS; MICE; RATS; SERINE ENDOPEPTIDASES; SPECIES SPECIFICITY;

ANIMALIA; CANIS FAMILIARIS; CRICETINAE;

EID: 20344406823     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1081/RRS-200054355     Document Type: Article

References (25)

1. Walls AF. Mast Cell Proteases in Asthma, In: Holgate S, Busse WW, Eds. Inflammatory Mechanisms in Asthma. New York: Marcel Dekker, 1998: 89-110.
2. He S, Walls AF. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol 1998, 125, 1491-1500.
3. He S, Walls AF. The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur J Pharmacol 1998, 352, 91-98.
4. Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF, Graham MF. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide. J Biol Chem 1997, 272, 7127-7131.
5. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 1991, 174, 821-825.
6. Tani K, Ogushi F, Kido H, Kawano T, Kunori Y, Kamimura T, Cui P, Sone S. Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol 2000, 67, 585-589.
7. Tunon de Lara JM, Okayama Y, McEuen AR, Heusser CH, Church MK, Walls AF. Release and inactivation of interleukin-4 by mast cells. Ann N Y Acad Sci 1994, 725, 50-58.
8. Vartio T, Seppa H, Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J Biol Chem 1981, 256, 471-477.
9. Takai S, Shiota N, Kobayashi S, Matsumura E, Miyazaki M. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta. FEBS Lett 1997, 412, 86-90.
10. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990, 265, 22348-22357.
11. Shiota N, Okunishi H, Fukamizu A, Sakonjo H, Kikumori M, Nishimura T, Nakagawa T, Murakami K, Miyazaki M. Activation of two angiotensin-generating systems in the balloon-injured artery. FEBS Lett 1993, 323, 239-242.
12. Saito K, Muto T, Tomimori Y, Imajo S, Maruoka H, Tanaka T, Yamashiro K, Fukuda Y. Mouse mast cell protease-1 cleaves angiotensin I to form angiotensin II. Biochem Biophys Res Commun 2003, 302, 773-777.
13. Caughey GH, Raymond WW, Wolters PJ. Angiotensin II generation by mast cell alpha- and beta-chymases. Biochimica Biophysica Acta 2000, 7480, 245-257.
14. Chandrasekharan UM, Sanker S, Glynias MJ, Karnik SS, Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 1996, 277, 502-505.
15. Le Trong H, Neurath H, Woodbury RG. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells. Proc Natl Acad Sci USA 1987, 84, 364-367.
16. Okunishi H, Miyazaki M, Toda N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 1984, 2, 277-284.
17. Okunishi H, Oka Y, Shiota N, Kawamoto T, Song K, Miyazaki M. Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol 1993, 62, 207-210.
18. Kunori Y, Koizumi M, Masegi T, Kasai H, Kawabata H, Yamazaki Y, Fukamizu A. Rodent alpha-chymases are elastase-like proteases. Eur J Biochem 2002, 269, 5921-5930.
19. Kido H, Fukusen N, Katunuma N. A simple method for purification of chymase from rat tongue and rat peritoneal cells. Anal Biochem 1984, 137, 449-453.
20. Miyazaki M, Takai S. Local angiotensin II-generating system in vascular tissues: The roles of chymase. Hypertens Res 2001, 24, 189-193.
21. Jin D, Takai S, Yamada M, Sakaguchi M, Miyazaki M. The functional ratio of chymase and angiotensin converting enzyme in angiotensin I-induced vascular contraction in monkeys, dogs and rats. Jpn J Pharmacol 2000, 84, 449-454.
22. Nishimura H, Buikema H, Baltatu O, Ganten D, Urata H. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system. Am J Physiol 1998, 275, H1307-H1312.
23. Muramatsu M, Katada J, Hayashi I, Majima M. Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J Biol Chem 2000, 275, 5545-5552.
24. Shiota N, Jin D, Takai S, Kawamura T, Koyama M, Nakamura N, Miyazaki M. Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension. FEBS Lett 1997, 406, 301-304.
25. Hoshino F, Urata H, Inoue Y, Saito Y, Yahiro E, Ideishi M, Arakawa K, Saku K. Chymase inhibitor improves survival in hamsters with myocardial infarction. J Cardiovasc Pharmacol 2003, 41 (Suppl 1), S11-S18.